This article has been nominated for the 2014 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards.
Executive Summary On 9 December 2013, DG Comp published its fourth report on the monitoring in Europe of patent settlements. Like its predecessors, the report welcomes the continuously low level of settlements that may give rise to antitrust concerns and trumpets that the overall number of settlements has increased, which it says demonstrates that criticisms of DG Comp’s enforcement policy against patent settlements are unfounded. A critical review of the report and its predecessors shows however a completely different reality. By promising the “highest antitrust scrutiny” to settlements containing any limitation on the generic’s freedom and a value transfer, the monitoring exercises have not surprisingly had a chilling effect — deterring companies from entering into settlements
Access to this article is restricted to subscribers
Already Subscribed? Sign-in